Compare SEGG & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SEGG | PMCB |
|---|---|---|
| Founded | 2015 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5M | 4.0M |
| IPO Year | 2018 | 2001 |
| Metric | SEGG | PMCB |
|---|---|---|
| Price | $1.03 | $126.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 167.6K |
| Earning Date | 11-02-2026 | 12-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 70.56 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,779,057.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.42 | $0.25 |
| 52 Week High | $4.65 | $1.51 |
| Indicator | SEGG | PMCB |
|---|---|---|
| Relative Strength Index (RSI) | 38.19 | 98.99 |
| Support Level | $0.71 | $0.60 |
| Resistance Level | $1.59 | N/A |
| Average True Range (ATR) | 0.36 | 0.17 |
| MACD | -0.01 | 0.42 |
| Stochastic Oscillator | 4.94 | 82.66 |
Sports Entertainment Gaming Global Corp is a world-wide sports, entertainment and gaming company operating at the intersection of digital content, fan engagement and regulated gaming. It is building an integrated ecosystem designed to connect fans to the games, events and experiences it care about in compliant, technology-enabled environments. It is operated as a single-reporting unit focused on its lottery and gaming platform, and its organizational structure, internal reporting systems, and resource allocation processes were aligned accordingly. The company owns and operates three premium domain brands: Sports.com, Concerts.com, and Lottery.com representing the company's three operating focuses: Sports, Entertainment, and Gaming.
PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.